Home Business China Recovering Fast from Covid

China has reported declining numbers of fever patients and critical COVID-19 cases nationwide as both peaks have passed less than a month after the country optimized its epidemic response in early December.

The country’s health authorities reported 59,938 COVID-related deaths in hospitals between Dec. 8, 2022 and Jan. 12, 2023.

“The number of critical cases in hospitals peaked on Jan. 5, totaling at 128,000 on the day,” said Jiao Yahui, head of the Bureau of Medical Administration under the National Health Commission (NHC), at a press conference held by the State Council joint COVID-19 prevention and control mechanism, on Saturday.

The number then began to drop with fluctuations, falling back to 105,000 on Jan. 12, Jiao said.

“At present, 75.3 percent of beds for severe cases are being used,” Jiao said, adding that the total number of intensive care beds is sufficient to meet the need for treatment.

PEAKS PASS

According to Jiao, the number of people seeking treatment at fever clinics peaked on Dec. 23, 2022 at about 2.87 million, and the figure has since been in continuous decline.

The number of fever patients fell to 477,000 on Jan. 12, a decrease of 83.3 percent from the peak daily figure.

Two weeks after the peak of fever patients, the number of critical cases in hospitals reached its peak, Jiao said.

The COVID-19 detection rate at fever clinics also continues to decline, peaking at 33.9 percent on Dec. 20, 2022. The number dropped to 10.8 percent on Jan. 12, Jiao added.

The proportion of positive COVID-19 tests among all hospital outpatients peaked at 5.7 percent on Dec. 19, 2022, and has since continued to drop, falling to 0.9 percent on Jan. 12, Jiao said.

People seeking treatment at general outpatient departments totaled nearly 9.14 million on Jan. 12, basically returning to the pre-epidemic level, Jiao said.

Regular medical services at hospitals are recovering gradually, Jiao said.

PROTECT THE VULNERABLE

According to the press conference, the majority of critical cases and COVID-related deaths are the elderly, most of whom have underlying issues.

The average age at the time of death was 80.3 years, said Jiao, adding that more than 90 percent of the deaths involved underlying issues, including cardiovascular diseases, advanced tumors, cerebrovascular diseases, respiratory diseases, metabolic diseases and renal insufficiency.

The average age of severe case patients is 75.5 years, said Jiao, adding that of the severe cases in hospitals on Jan. 12, 92.8 percent have severe underlying issues complicated with COVID-19 infection.

In the next step, efforts will be made in health monitoring and referral services for the elderly, pregnant women, children and patients with underlying issues, said Mi Feng, an NHC spokesperson, at the press conference.

Mi called for ensuring the smooth channel for transferring critical cases, treating patients with integrated Chinese and Western medicine and further boosting vaccination among the elderly.

He also underlined enhancing the capacity of medical services in rural areas. 

You may also like

logo-white

Your Trusted Source for Capital Markets & Related News

© 2023 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.